Welcome to the Abstracts Submission Site
Call for Abstracts
DEADLINE for submission is 11:59p ET, Friday, July 14, 2023. All authors will be notified via email on or by August 11, 2023.
BRAINWeek invites you to submit abstracts for posters to be presented at the 2023 BRAINWeek National Conference. Please review the guidelines below.
Abstracts may be research oriented, or evidence based, and relevant to specialists and medical practitioners who manage CNS disorders. They may include medication management, devices, and digital therapeutics. Abstracts may be a summary of research findings or a review of current evidence-based recommendations for clinical applications that are pertinent to medical practitioners and specialists who treat CNS patients.
- At least one presenting author or presenter of accepted abstracts must register at the current registration rate to attend the BRAINWeek National Conference. Submission of an abstract does not automatically register you for the conference.
- BRAINWeek will accept abstracts that have already been presented at other medical conferences.
- Abstracts should be 1300 words or less, with maximums as defined below. (Titles, author names, and affiliations are not included in that word count)
- Purpose: 350 words
- Methods: 350 words
- Results: 400 words
- Conclusions: 200 words
Disclosures: BRAINWeek requires faculty and poster authors/presenters who have an interest in selling a technology, program, product, and/or service to healthcare professionals to disclose this information in order to be considered for and/or present at any BRAINWeek educational session.
Publication: If your abstract is accepted, you will be notified on or by August 11, and the abstract will be posted online by August 30. Only accepted abstracts will be posted online. Posters will not be published online.